‘Thursday’s child has far to go’—interpreting subgroups and the STAMPEDE trial

Benzer Materyaller

• Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
  Yazar:: Gilson, C., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Interpreting 4C-Seq data: how far can we go?
  Yazar:: Raviram, Ramya, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?
  Yazar:: Petry, Nancy M., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
  Yazar:: Sydes, Matthew R, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Women--how far still to go?
  Yazar:: Walker, A R
  Baskı/Yayın Bilgisi: (1999)